FR7524M - - Google Patents

Info

Publication number
FR7524M
FR7524M FR133219A FR133219A FR7524M FR 7524 M FR7524 M FR 7524M FR 133219 A FR133219 A FR 133219A FR 133219 A FR133219 A FR 133219A FR 7524 M FR7524 M FR 7524M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR133219A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR133219A priority Critical patent/FR7524M/fr
Application granted granted Critical
Publication of FR7524M publication Critical patent/FR7524M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
FR133219A 1968-03-12 1968-03-12 Expired FR7524M (US20030139425A1-20030724-C00009.png)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR133219A FR7524M (US20030139425A1-20030724-C00009.png) 1968-03-12 1968-03-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR133219A FR7524M (US20030139425A1-20030724-C00009.png) 1968-03-12 1968-03-12

Publications (1)

Publication Number Publication Date
FR7524M true FR7524M (US20030139425A1-20030724-C00009.png) 1969-12-15

Family

ID=8643550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR133219A Expired FR7524M (US20030139425A1-20030724-C00009.png) 1968-03-12 1968-03-12

Country Status (1)

Country Link
FR (1) FR7524M (US20030139425A1-20030724-C00009.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424272A1 (fr) * 1978-04-27 1979-11-23 Farmaceutici Geymonat Sud Procede pour la preparation de chlorhydrate de p-chloro-phenoxyacetyl-piperonylpiperazine
EP0090203A2 (en) * 1982-03-29 1983-10-05 RAVIZZA S.p.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
EP0090202A2 (en) * 1982-03-29 1983-10-05 RAVIZZA S.p.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
FR2578742A1 (fr) * 1985-03-18 1986-09-19 Bouchard Laboratoires Nouvelles compositions pharmaceutiques a action protectrice contre la senescence a base de fipexide et le procede pour les obtenir
WO1998056771A2 (en) * 1997-06-12 1998-12-17 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424272A1 (fr) * 1978-04-27 1979-11-23 Farmaceutici Geymonat Sud Procede pour la preparation de chlorhydrate de p-chloro-phenoxyacetyl-piperonylpiperazine
EP0090203A2 (en) * 1982-03-29 1983-10-05 RAVIZZA S.p.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
EP0090202A2 (en) * 1982-03-29 1983-10-05 RAVIZZA S.p.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
EP0090202A3 (en) * 1982-03-29 1984-05-23 Ravizza S.P.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
EP0090203A3 (en) * 1982-03-29 1984-05-23 Ravizza S.P.A. Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
FR2578742A1 (fr) * 1985-03-18 1986-09-19 Bouchard Laboratoires Nouvelles compositions pharmaceutiques a action protectrice contre la senescence a base de fipexide et le procede pour les obtenir
WO1998056771A2 (en) * 1997-06-12 1998-12-17 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
WO1998056771A3 (en) * 1997-06-12 1999-03-11 Schering Ag Piperazine derivatives and their use as anti-inflammatory agents
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
EP1254899A2 (en) * 1997-06-12 2002-11-06 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
EP1254899A3 (en) * 1997-06-12 2003-02-19 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6534509B1 (en) 1997-06-12 2003-03-18 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6541476B1 (en) 1997-06-12 2003-04-01 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6555537B2 (en) 1997-06-12 2003-04-29 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6573266B1 (en) 1997-06-12 2003-06-03 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6972290B2 (en) 1997-06-12 2005-12-06 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6977258B2 (en) 1997-06-12 2005-12-20 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US7268140B2 (en) 1997-06-12 2007-09-11 Schering Ag Piperazine derivatives and their use as anti-inflammatory agents

Similar Documents

Publication Publication Date Title
AU1946070A (US20030139425A1-20030724-C00009.png)
AU428130B2 (US20030139425A1-20030724-C00009.png)
AU2374870A (US20030139425A1-20030724-C00009.png)
AU5184069A (US20030139425A1-20030724-C00009.png)
AU6171569A (US20030139425A1-20030724-C00009.png)
AU429879B2 (US20030139425A1-20030724-C00009.png)
AU416157B2 (US20030139425A1-20030724-C00009.png)
AU2581067A (US20030139425A1-20030724-C00009.png)
FR1568008A (US20030139425A1-20030724-C00009.png)
AU4811568A (US20030139425A1-20030724-C00009.png)
AU421558B1 (US20030139425A1-20030724-C00009.png)
AU4744468A (US20030139425A1-20030724-C00009.png)
AU3789668A (US20030139425A1-20030724-C00009.png)
AU3224368A (US20030139425A1-20030724-C00009.png)
AU2580267A (US20030139425A1-20030724-C00009.png)
AU479393A (US20030139425A1-20030724-C00009.png)
BE642636A (US20030139425A1-20030724-C00009.png)
AU4558658A (US20030139425A1-20030724-C00009.png)
AU463027A (US20030139425A1-20030724-C00009.png)
AU4464266A (US20030139425A1-20030724-C00009.png)
BE709484A (US20030139425A1-20030724-C00009.png)
AU479894A (US20030139425A1-20030724-C00009.png)
AU4270368A (US20030139425A1-20030724-C00009.png)
AU4224469A (US20030139425A1-20030724-C00009.png)
AU3083868A (US20030139425A1-20030724-C00009.png)